ALD-151

N/A

Report date: 2023/02/19 17:50:45

Base Information

Drug NameALD-151

Drug Alias NameALD-151

ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Adult stem cell therapyCell and gene therapy > Cell therapy > Source of cells > Umbilical cord blood-derived

Mechanisms of ActionCell replacements

TargetsNot applicable

Therapy Area/IndicationsPrimary Immunodeficiency DiseasesMetabolism, Inborn ErrorsMyelodysplastic Syndromes +[5]

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesNuo Therapeutics

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesNuo Therapeutics Aldagen Inc

Active IndicationsN/A

Inactive IndicationsPrimary Immunodeficiency DiseasesMetabolism, Inborn ErrorsMyelodysplastic Syndromes +[5]

Other Information

ATC CodeN/A